metoprolol has been researched along with Diabetic Glomerulosclerosis in 24 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antihypertensive treatment with enalapril reduced proteinuria in patients with diabetic nephropathy more than an equally effective antihypertensive treatment with metoprolol." | 9.06 | Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. ( Aurell, M; Björck, S; Johnsen, SA; Mulec, H; Nyberg, G, 1990) |
| "We compared the effects of the angiotensin-converting enzyme inhibitor enalapril and a conventional antihypertensive regimen (hydralazine and metoprolol) on kidney function, albuminuria, and glomerular ultrastructure in hypertensive diabetic and nondiabetic rats." | 7.68 | Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. ( Allen, TJ; Clarke, BE; Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC; Papazoglou, D, 1990) |
| "8 years) with microalbuminuria 31 (19-160) microg/min were randomised to treatment with enalapril (group 1, n = 7) or metoprolol (group 2, n = 6)." | 5.09 | Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus. ( Bangstad, HJ; Dahlquist, G; Osterby, R; Persson, B; Rudberg, S, 1999) |
| "Antihypertensive treatment with enalapril reduced proteinuria in patients with diabetic nephropathy more than an equally effective antihypertensive treatment with metoprolol." | 5.06 | Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. ( Aurell, M; Björck, S; Johnsen, SA; Mulec, H; Nyberg, G, 1990) |
| "We compared the effects of the angiotensin-converting enzyme inhibitor enalapril and a conventional antihypertensive regimen (hydralazine and metoprolol) on kidney function, albuminuria, and glomerular ultrastructure in hypertensive diabetic and nondiabetic rats." | 3.68 | Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. ( Allen, TJ; Clarke, BE; Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC; Papazoglou, D, 1990) |
| "Treatment with enalapril can reduce the rate of decline in kidney function in patients with diabetic nephropathy more than equally effective antihypertensive treatment with metoprolol." | 2.67 | Renal protective effect of enalapril in diabetic nephropathy. ( Aurell, M; Björck, S; Johnsen, SA; Mulec, H; Nordén, G, 1992) |
| "Five patients with incipient diabetic nephropathy participated in a long-term study." | 2.66 | Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy. ( Christensen, CK; Mogensen, CE, 1986) |
| "Ramipril treatment was associated with a significantly lower risk of DM in African Americans with hypertensive kidney disease than amlodipine or metoprolol treatment." | 1.33 | Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. ( Agodoa, LY; Appel, LJ; Cheek, D; Contreras, G; Gassman, J; Lash, JP; Miller, ER; Randall, OS; Thornley-Brown, D; Wang, X; Wright, JT, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, LS | 1 |
| Bai, WW | 1 |
| Xiang, GD | 1 |
| Yue, L | 1 |
| Sun, HL | 1 |
| Thornley-Brown, D | 1 |
| Wang, X | 1 |
| Wright, JT | 1 |
| Randall, OS | 1 |
| Miller, ER | 1 |
| Lash, JP | 1 |
| Gassman, J | 1 |
| Contreras, G | 1 |
| Appel, LJ | 1 |
| Agodoa, LY | 1 |
| Cheek, D | 1 |
| Parving, HH | 3 |
| Andersen, AR | 1 |
| Smidt, UM | 2 |
| Svendsen, PA | 1 |
| Mogensen, CE | 3 |
| Mulec, H | 3 |
| Johnsen, SA | 3 |
| Björck, S | 3 |
| Rossing, P | 1 |
| Hommel, E | 2 |
| Rudberg, S | 4 |
| Sätterström, G | 1 |
| Dahlqvist, R | 1 |
| Dahlquist, G | 2 |
| Sawicki, PT | 2 |
| Osterby, R | 3 |
| Bangstad, HJ | 3 |
| Persson, B | 1 |
| Nyberg, G | 2 |
| Gulmann, C | 1 |
| Teschner, M | 1 |
| Schaefer, RM | 1 |
| Bahner, U | 1 |
| Heidland, A | 1 |
| Yeo, WW | 1 |
| Ramsay, LE | 1 |
| Jackson, PR | 1 |
| Nordén, G | 1 |
| Aurell, M | 2 |
| Pedersen, MM | 1 |
| Christensen, CK | 2 |
| Hansen, KW | 1 |
| Christiansen, JS | 1 |
| Cooper, ME | 1 |
| Allen, TJ | 1 |
| O'Brien, RC | 1 |
| Papazoglou, D | 1 |
| Clarke, BE | 1 |
| Jerums, G | 1 |
| Doyle, AE | 1 |
| Sawicki, P | 1 |
| Heinemann, L | 1 |
| Mühlhauser, I | 1 |
| Baba, T | 1 |
| Mathiesen, ER | 1 |
| Friedman, PJ | 1 |
| Dunn, PJ | 1 |
| Jury, DR | 1 |
| Ashouri, OS | 1 |
1 review available for metoprolol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
[Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Dia | 1992 |
8 trials available for metoprolol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Long-term enalapril treatment in diabetic nephropathy.
Topics: Adult; Blood Pressure; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Humans; Metopr | 1994 |
Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Topics: Adult; Albuminuria; Antihypertensive Agents; Cohort Studies; Diabetic Nephropathies; Female; Forecas | 1994 |
Indomethacin but not metoprolol reduces exercise-induced albumin excretion rate in type 1 diabetic patients with microalbuminuria.
Topics: Adult; Albuminuria; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies | 1993 |
Stabilization of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimens. Diabetes Treatment and Teaching Programmes Working Group.
Topics: Adult; Antihypertensive Agents; Diabetic Nephropathies; Felodipine; Female; Follow-Up Studies; Glome | 1997 |
Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitor | 1999 |
Renal protective effect of enalapril in diabetic nephropathy.
Topics: Adult; Blood Pressure; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Humans; Kidney | 1992 |
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Diabetic Nephropathies; Enalapril; Humans; Metoprolol; Middle Ag | 1990 |
Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropath | 1986 |
15 other studies available for metoprolol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Clinical evaluation of valsartan and metoprolol tartrate in treatment of diabetic nephropathy with positive β1-adrenergic and anti-angiotensin II type 1 receptor antibody.
Topics: Aged; Autoantibodies; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Mal | 2012 |
Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Antihypertensive Agents; Black or African American; | 2006 |
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus; Diabetic Nephropathies; Diuretics | 1983 |
Antihypertensive treatment inhibiting the progression of diabetic nephropathy.
Topics: Adult; Blood Pressure; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Hypertension; Mal | 1980 |
On glomerular structural alterations in type-1 diabetes. Companions of early diabetic glomerulopathy.
Topics: Adult; Albuminuria; Capillaries; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enalapril; Extra | 2001 |
The juxtaglomerular apparatus in young type-1 diabetic patients with microalbuminuria. Effect of antihypertensive treatment.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitor | 2001 |
Renal protective effect of enalapril in diabetic nephropathy.
Topics: Diabetic Nephropathies; Enalapril; Humans; Hypertension, Renal; Metoprolol | 1992 |
ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
Topics: Adult; Albuminuria; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, | 1991 |
Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
Topics: Administration, Oral; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Melli | 1990 |
Enalapril and metoprolol in diabetic nephropathy.
Topics: Blood Pressure; Diabetic Nephropathies; Enalapril; Humans; Metoprolol | 1990 |
Enalapril and metoprolol in diabetic nephropathy.
Topics: Diabetic Nephropathies; Enalapril; Humans; Metoprolol | 1990 |
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril?
Topics: Albuminuria; Animals; Basement Membrane; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic N | 1989 |
Converting enzyme-inhibition in diabetic nephropathy.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Furosemid | 1989 |
Metoprolol and albumin excretion in diabetes.
Topics: Adult; Albuminuria; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Male; Metoprolol; Mid | 1986 |
Metoprolol-induced hyperkalemia in a diabetic with advanced renal failure.
Topics: Diabetic Nephropathies; Humans; Hyperkalemia; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged | 1985 |